SAFE-BioPharma, LLC Introduces Cyber Security Consulting Service For Life Science And Healthcare Companies

TEANECK, N.J.--(BUSINESS WIRE)--SAFE-BioPharma Association today announced creation of SBP Digital Trust Consulting, a resource of internationally recognized identity and access management (IAM) policy and technical experts for life science and healthcare companies seeking to develop improved cyber security strategies.

“Identity and access management are critical to effective cyber security,” explains Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. “Any biopharmaceutical or healthcare organization seeking to evaluate or improve its cybersecurity through improved identity and access management strategies would be prudent to consider the services of the experts participating in SBP Digital Trust Consulting.”

SAFE-BioPharma is the non-profit coalition responsible for the on-going development and implementation of the global SAFE-BioPharma® digital identity and signature standard.

Personnel available through SBP Digital Trust Consulting work with policy, technical, security, and compliance staffs to assess and develop IAM strategies, build IAM system requirements, develop required certificate and credential policies and practice statements, and to assist in required procurement actions. Unaffiliated with vendors or other commercial suppliers, they are committed to objectivity in their recommendations.

SBP Digital Trust Consulting also provides expert counseling on identity and access management considerations in the areas of healthcare and biopharmaceutical business process improvement, regulatory compliance, and communications outreach.

Specific capabilities include:

• IAM policy and compliance - detailed knowledge and proven application of IAM life cycle policy requirements and developing certificate/credential policies and practice statements, token management for both PKI certificates and non-PKI credentials, and certificate and credential life cycle management;
• IAM system technical architecture that complies with applicable national and international regulations;
• IAM system security requirements (NIST, ISO, ETSI) and implementation;
• IAM and privacy/confidentiality legal issues;
• Biopharmaceutical-specific business processes expertise;
• Biopharmaceutical industry regulatory expertise;
• Public relations and communications targeting IAM and cybersecurity issues.

SAFE-BioPharma also has access to a full range of other services through contractual relationships with several leading consulting firms.

About SAFE-BioPharma Association

SAFE-BioPharma pharmaceutical members include AbbVie, Astellas, AstraZeneca, Bayer Healthcare, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Merck, Pfizer, and Sanofi, among others. For more information about SAFE-BioPharma, visit: www.safe-biopharma.org.

Release Summary

SAFE-BioPharma Association is starting a consulting arm for experts in Identity and Access Management in pharmaceuticals and healthcare.

Help employers find you! Check out all the jobs and post your resume.